IP Library Granted Patent US 9,375,348
Granted Patent B2
US 9,375,348 · App. 14/181,851 · Granted Jun 28, 2016

Systems and methods for a membrane-free electrolysis pump for an intraocular implant

Inventor: Nicholas M. Gunn (Newport Beach, CA)
Assignee: Novartis AG
A61F9/00781F04B19/006F04B43/043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,375,348
App. No.
14/181,851
Granted
Jun 28, 2016
Kind
B2
Abstract

A microfluidic pump for implantation proximate an eye of a patient is provided herein. The pump includes a first substrate portion and a second substrate portion adjacent the first and a chamber that has a bottom surface and a top surface provided by the first and second substrate portions. A gas is produced within the chamber so that it displaces fluid from the chamber. The pump also includes an inlet channel and an outlet channel coupled to the chamber, the inlet channel being separated from the chamber by a first gap and the outlet channel separated from the chamber by a second gap. The gaps inhibit the gas from moving out of the chamber. Other microfluidic pumps and intraocular devices are also disclosed.

Claims (26)

1. A microfluidic pump for implantation proximate an eye of a patient, the microfluidic pump comprising:

a first substrate portion;

a second substrate portion adjacent to the first substrate portion;

a channel defined by and between the first and second substrate portions and having a proximal end and a distal end, the channel having a first valve in the proximal end and a second valve in the distal end; and

a chamber having a bottom surface, side surfaces, and a top surface, wherein the top surface is provided by a rigid, liquid-permeable wall, the chamber producing a gas within the chamber that displaces fluid within the chamber and within the channel, the rigid, liquid-permeable wall being in fluid communication with the channel.

2. The microfluidic pump of claim 1 , wherein the gas comprises O 2 and H 2 .

3. The microfluidic pump of claim 1 , wherein the wall is formed from an open-cell foam material.

4. The microfluidic pump of claim 1 , wherein the chamber comprises a metal layer disposed on the side surfaces and on the bottom surface of the chamber such that the metal layer does not contact at least one of two electrodes within the chamber.

5. The microfluidic pump of claim 1 , wherein the wall is formed from a hydrophilic material.

6. The microfluidic pump of claim 1 , wherein the wall comprises a plurality of micro-pores.

7. The microfluidic pump of claim 1 , wherein the first and second valves are check valves.

8. The microfluidic pump of claim 1 , wherein the first and second substrate portions are made of glass.

9. The microfluidic pump of claim 1 , further comprising a dividing member, the dividing member dividing the rigid, liquid-permeable wall into a first portion and a second portion and preventing fluid from passing through the channel without entering the chamber through the wall.

10. An intraocular device for regulating pressure within an eye of a patient, the intraocular device comprising:

a plate having a cavity therein;

a flexible tube having a proximal end and a distal end, the proximal end configured to insert into an anterior chamber of the eye and the distal end coupled to the plate; and

a microfluidic pump configured within the cavity of the plate, the microfluidic pump comprising:

a first substrate portion;

a second substrate portion adjacent to the first substrate portion;

a channel defined by and between the first and second substrate portions and in communication with the flexible tube; and

a chamber having a bottom surface, side surfaces, and a top surface, wherein the top surface is provided by a liquid-permeable wall, a gas being produced within the chamber that displaces fluid from within the chamber into the channel, the rigid, liquid-permeable wall being in fluid communication with the channel.

11. The intraocular device of claim 10 , wherein the channel comprises a first valve at a proximal end of the channel and a second valve at a distal end of the channel.

12. The intraocular device of claim 10 , further comprising a pressure sensor coupled to the flexible tube to measure a pressure within an anterior chamber of the eye.

13. The intraocular device of claim 10 , wherein the chamber is an electrolysis chamber that produces a gas from a liquid.

14. The intraocular device of claim 13 , wherein the gas comprises H 2 and O 2 and the liquid is aqueous humor from the eye.

15. The intraocular device of claim 10 , further comprising a dividing member, the dividing member dividing the wall into a first portion and a second portion and preventing fluid from passing through the channel without entering the chamber through the wall.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2014
From: GUNN, NICHOLAS M.
To: ALCON RESEARCH, LTD.
Reel/Frame 032228/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2014
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 032228/0197 →
Continuity (1)
Related Publication 20150230984A1 · Aug 20, 2015